101:@0.890183:0.033217:0.921227:0.033217:0.921227:0.013052:0.890183:0.013052:0.010348:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
tively,  and given the  high prevalence,  sensitivity  and :@0.076190:0.084931:0.485142:0.084931:0.485142:0.069149:0.076190:0.069149:0.005125:0.003024:0.008376:0.009827:0.003024:0.008104:0.004188:0.004865:0.006592:0.010326:0.009223:0.010357:0.006592:0.010175:0.003024:0.008376:0.009827:0.009223:0.006592:0.005125:0.009223:0.009827:0.004188:0.002389:0.009223:0.003024:0.010175:0.009223:0.006592:0.010311:0.004551:0.009827:0.008376:0.010326:0.003024:0.009827:0.009223:0.009782:0.009827:0.004188:0.004188:0.002389:0.005866:0.009827:0.009223:0.005866:0.003024:0.005125:0.003024:0.008376:0.003024:0.005125:0.008104:0.004188:0.002419:0.010326:0.009223:0.010357:0.004188
2:@0.117864:0.079633:0.122722:0.079633:0.122722:0.070479:0.117864:0.070479:0.004858
specificity of the test, makes it an ideal screening tool :@0.076187:0.099559:0.485142:0.099559:0.485142:0.083777:0.076187:0.083777:0.005866:0.010311:0.009827:0.009782:0.003024:0.003681:0.003681:0.009782:0.003024:0.005125:0.008104:0.005791:0.009903:0.004747:0.005791:0.005125:0.009223:0.009827:0.005791:0.005125:0.009827:0.005866:0.005125:0.004188:0.005791:0.014182:0.010326:0.007590:0.009827:0.005866:0.005791:0.003024:0.005125:0.005791:0.010326:0.009223:0.005791:0.003024:0.010357:0.009827:0.010326:0.003024:0.005791:0.005866:0.009782:0.004551:0.009827:0.009827:0.009223:0.003024:0.009223:0.010175:0.005775:0.005125:0.009903:0.009903:0.003024:0.004188
in patients with diabetes, hypertension,  high cardio-:@0.076187:0.114187:0.480924:0.114187:0.480924:0.098405:0.076187:0.098405:0.003024:0.009223:0.008648:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.008648:0.012564:0.003024:0.005125:0.009223:0.008648:0.010357:0.003024:0.010326:0.010311:0.009827:0.005125:0.009827:0.005866:0.004188:0.008648:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188:0.004188:0.004445:0.009223:0.003024:0.010175:0.009223:0.008648:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.005020
vascular risk, and kidney-disease risk. The interpretation :@0.076187:0.128816:0.485157:0.128816:0.485157:0.113033:0.076187:0.113033:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.005020:0.004551:0.003024:0.005866:0.007590:0.004188:0.005020:0.010326:0.009223:0.010357:0.005020:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.005020:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.005020:0.004551:0.003024:0.005866:0.007590:0.004188:0.005020:0.006441:0.009223:0.009827:0.005004:0.003024:0.009223:0.005125:0.009827:0.004551:0.010311:0.004551:0.009827:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
of the ACR should always be considered in conjunction :@0.076187:0.143444:0.485142:0.143444:0.485142:0.127661:0.076187:0.127661:0.009903:0.004747:0.004112:0.005125:0.009223:0.009827:0.004112:0.011188:0.012292:0.009177:0.004112:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004127:0.010326:0.003024:0.012564:0.010326:0.008104:0.005866:0.004127:0.010311:0.009827:0.004127:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.009827:0.010357:0.004112:0.003024:0.009223:0.004127:0.009782:0.009903:0.009223:0.003069:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188
with the level  of albuminuria (see Table 1) and eGFR :@0.076187:0.158072:0.485112:0.158072:0.485112:0.142289:0.076187:0.142289:0.012564:0.003024:0.005125:0.009223:0.006788:0.005125:0.009223:0.009827:0.006788:0.003024:0.009827:0.008376:0.009827:0.003024:0.004188:0.002616:0.009903:0.004747:0.006788:0.010326:0.003024:0.010311:0.009192:0.014182:0.003024:0.009223:0.009192:0.004551:0.003024:0.010326:0.006788:0.005579:0.005866:0.009827:0.009827:0.006788:0.006441:0.010326:0.010311:0.003024:0.009827:0.006788:0.008376:0.005579:0.006788:0.010326:0.009223:0.010357:0.006788:0.009827:0.013184:0.007333:0.009177:0.004188
(see Figure 1).  Any patient in the red or yellow zones in :@0.076187:0.172700:0.485134:0.172720:0.485134:0.156937:0.076187:0.156917:0.005579:0.005866:0.009827:0.009827:0.004505:0.007333:0.003024:0.010175:0.009192:0.004551:0.009827:0.004490:0.008376:0.005579:0.004188:0.004875:0.004505:0.011188:0.009223:0.008104:0.004505:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004505:0.003024:0.009223:0.004505:0.005125:0.009223:0.009827:0.004505:0.004551:0.009827:0.010357:0.004505:0.009903:0.004551:0.004490:0.008104:0.009827:0.003024:0.003024:0.009903:0.012564:0.004505:0.006426:0.009903:0.009223:0.009827:0.005866:0.004490:0.003024:0.009223:0.623065
3:@0.178543:0.167421:0.183401:0.167421:0.183401:0.158267:0.178543:0.158267:0.004858
Figure 1 or with moderate to high levels of albuminuria :@0.076194:0.187348:0.485134:0.187348:0.485134:0.171565:0.076194:0.171565:0.007333:0.003024:0.010175:0.009192:0.004551:0.009827:0.005125:0.008376:0.005125:0.009903:0.004551:0.005125:0.012564:0.003024:0.005125:0.009223:0.005125:0.014182:0.009903:0.010357:0.009827:0.004551:0.010326:0.005125:0.009827:0.005125:0.005125:0.009903:0.005125:0.009223:0.003024:0.010175:0.009223:0.005125:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.005140:0.009903:0.004747:0.005125:0.010326:0.003024:0.010311:0.009192:0.014182:0.003024:0.009223:0.009192:0.004551:0.003024:0.010326:0.004188
(Table 1) should ideally be referred to a nephrologist or :@0.076194:0.201976:0.485164:0.201976:0.485164:0.186194:0.076194:0.186194:0.005579:0.006441:0.010326:0.010311:0.003024:0.009827:0.004642:0.008376:0.005579:0.004642:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004642:0.003024:0.010357:0.009827:0.010326:0.003024:0.003024:0.008104:0.004642:0.010311:0.009827:0.004642:0.004551:0.009827:0.004747:0.009827:0.004551:0.004551:0.009827:0.010357:0.004626:0.005125:0.009903:0.004626:0.010326:0.004642:0.009223:0.009827:0.010311:0.009223:0.004551:0.009903:0.003024:0.009903:0.010175:0.003024:0.005866:0.005125:0.004626:0.009903:0.004551:0.004188
specialist physician. :@0.076194:0.216604:0.223816:0.216604:0.223816:0.200822:0.076194:0.200822:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.005866:0.005125:0.004188:0.010311:0.009223:0.008104:0.005866:0.003024:0.009782:0.003024:0.010326:0.009223:0.004188:0.004188
micro-albuminuria:@0.076190:0.248316:0.226037:0.248316:0.226037:0.229985:0.076190:0.229985:0.015119:0.004032:0.010751:0.005376:0.010751:0.007056:0.011087:0.004032:0.011087:0.010079:0.015791:0.004032:0.010079:0.010079:0.005376:0.004032:0.011087
Micro-albuminuria is the presence of small quantities of :@0.076190:0.265120:0.485145:0.265120:0.485145:0.249337:0.076190:0.249337:0.013743:0.002873:0.009631:0.004400:0.009752:0.004868:0.010175:0.002873:0.010160:0.009041:0.014030:0.002873:0.009071:0.009041:0.004400:0.002873:0.010175:0.005775:0.002873:0.005715:0.005775:0.004974:0.009071:0.009676:0.005775:0.010160:0.004400:0.009676:0.005715:0.009676:0.009071:0.009631:0.009676:0.005775:0.009752:0.004596:0.005775:0.005715:0.014030:0.010175:0.002873:0.002873:0.005775:0.010160:0.009041:0.010175:0.009071:0.004974:0.002873:0.004974:0.002873:0.009676:0.005715:0.005775:0.009752:0.004747:0.004188
albumin in the urine – usually below standard dipstick de-:@0.076190:0.279748:0.480897:0.279748:0.480897:0.263965:0.076190:0.263965:0.010175:0.002873:0.010160:0.009041:0.014030:0.002873:0.009071:0.003568:0.002873:0.009071:0.003568:0.004974:0.009071:0.009676:0.003568:0.009041:0.004400:0.002873:0.009071:0.009676:0.003568:0.007408:0.003568:0.009041:0.005715:0.009041:0.010175:0.002873:0.002873:0.007953:0.003568:0.010160:0.009676:0.002873:0.009752:0.012413:0.003568:0.005715:0.004974:0.010175:0.009071:0.010205:0.010175:0.004400:0.010205:0.003568:0.010205:0.002873:0.010160:0.005715:0.004974:0.002873:0.009631:0.007439:0.003568:0.010205:0.009676:0.005020
tection. It represents leakage of albumin into the urine as :@0.076190:0.294376:0.485191:0.294376:0.485191:0.278593:0.076190:0.278593:0.004974:0.009676:0.009631:0.004974:0.002873:0.009752:0.009071:0.004037:0.003780:0.003266:0.004974:0.003780:0.004400:0.009676:0.010160:0.004400:0.009676:0.005715:0.009676:0.009071:0.004974:0.005715:0.003780:0.002873:0.009676:0.010175:0.007439:0.010175:0.010024:0.009676:0.003780:0.009752:0.004596:0.003780:0.010175:0.002873:0.010160:0.009041:0.014030:0.002873:0.009071:0.003780:0.002873:0.009071:0.004974:0.009752:0.003780:0.004974:0.009071:0.009676:0.003780:0.009041:0.004400:0.002873:0.009071:0.009676:0.003780:0.010175:0.005866:0.004188
a result of endothelial dysfunction in the glomerulus, but :@0.076190:0.309004:0.485115:0.309004:0.485115:0.293221:0.076190:0.293221:0.010175:0.004747:0.004400:0.009676:0.005715:0.009041:0.002873:0.004974:0.004747:0.009752:0.004596:0.004747:0.009676:0.009071:0.010205:0.009752:0.004974:0.009071:0.009676:0.002873:0.002873:0.010175:0.002873:0.004747:0.010205:0.007953:0.005715:0.004596:0.009041:0.009071:0.009631:0.004974:0.002873:0.009752:0.009071:0.004747:0.002873:0.009071:0.004747:0.004974:0.009071:0.009676:0.004747:0.010024:0.002873:0.009752:0.014030:0.009676:0.004400:0.009041:0.002873:0.009041:0.005715:0.004037:0.004747:0.010160:0.009041:0.005125:0.004188
it is now recognised as a marker of generalised endothe-:@0.076190:0.323632:0.480972:0.323632:0.480972:0.307849:0.076190:0.307849:0.002873:0.004974:0.003750:0.002873:0.005715:0.003750:0.009071:0.009752:0.012413:0.003750:0.004400:0.009676:0.009631:0.009752:0.010024:0.009071:0.002873:0.005715:0.009676:0.010205:0.003750:0.010175:0.005715:0.003750:0.010175:0.003750:0.014030:0.010175:0.004400:0.007439:0.009676:0.004400:0.003750:0.009752:0.004596:0.003750:0.010024:0.009676:0.009071:0.009676:0.004400:0.010175:0.002873:0.002873:0.005715:0.009676:0.010205:0.003750:0.009676:0.009071:0.010205:0.009752:0.004974:0.009071:0.009676:0.005020
lial dysfunction and CV risk. For example, in the HOpE :@0.076190:0.338260:0.485145:0.338260:0.485145:0.322477:0.076190:0.322477:0.002873:0.002873:0.010175:0.002873:0.006864:0.010205:0.007953:0.005715:0.004596:0.009041:0.009071:0.009631:0.004974:0.002873:0.009752:0.009071:0.006864:0.010175:0.009071:0.010205:0.006864:0.012141:0.010462:0.006864:0.004400:0.002873:0.005715:0.007439:0.004037:0.006864:0.007182:0.009752:0.004400:0.006864:0.009676:0.007106:0.010175:0.014030:0.010160:0.002873:0.009676:0.004037:0.006864:0.002873:0.009071:0.006864:0.004974:0.009071:0.009676:0.006864:0.010175:0.012987:0.008799:0.008104:0.004188
study which included people >55 years, with a history of :@0.076190:0.352888:0.485130:0.352888:0.485130:0.337105:0.076190:0.337105:0.005715:0.004974:0.009041:0.010205:0.007953:0.004642:0.012413:0.009071:0.002873:0.009631:0.009071:0.004642:0.002873:0.009071:0.009631:0.002873:0.009041:0.010205:0.009676:0.010205:0.004642:0.010160:0.009676:0.009752:0.010160:0.002873:0.009676:0.004642:0.009011:0.008225:0.008225:0.004642:0.007953:0.009676:0.010175:0.004400:0.005715:0.004037:0.004642:0.012413:0.002873:0.004974:0.009071:0.004642:0.010175:0.004642:0.009071:0.002873:0.005715:0.004974:0.009752:0.004400:0.007953:0.004642:0.009752:0.004747:0.004188
cardiovascular  disease  or  diabetes  with  one  other  risk :@0.076190:0.367516:0.485100:0.367516:0.485100:0.351733:0.076190:0.351733:0.009631:0.010175:0.004400:0.010205:0.002873:0.009752:0.008225:0.010175:0.005715:0.009631:0.009041:0.002873:0.010175:0.004400:0.004188:0.002888:0.010205:0.002873:0.005715:0.009676:0.010175:0.005715:0.009676:0.004188:0.002888:0.009752:0.004400:0.004188:0.002888:0.010205:0.002873:0.010175:0.010160:0.009676:0.004974:0.009676:0.005715:0.004188:0.002888:0.012413:0.002873:0.004974:0.009071:0.004188:0.002888:0.009752:0.009071:0.009676:0.004188:0.002888:0.009752:0.004974:0.009071:0.009676:0.004400:0.004188:0.002888:0.004400:0.002873:0.005715:0.007590:0.004188
factor, micro-albuminuria was present in 32.6% of those :@0.076190:0.382144:0.485145:0.382144:0.485145:0.366362:0.076190:0.366362:0.004596:0.010175:0.009631:0.004974:0.009752:0.004400:0.004037:0.005579:0.014030:0.002873:0.009631:0.004400:0.009752:0.004868:0.010175:0.002873:0.010160:0.009041:0.014030:0.002873:0.009071:0.009041:0.004400:0.002873:0.010175:0.005579:0.012413:0.010175:0.005715:0.005579:0.010160:0.004400:0.009676:0.005715:0.009676:0.009071:0.004974:0.005579:0.002873:0.009071:0.005579:0.008225:0.008225:0.004037:0.008225:0.011566:0.005579:0.009752:0.004596:0.005579:0.004974:0.009071:0.009752:0.005715:0.009827:0.004188
with  diabetes  and  14.8%  in  those  without  at  baseline.  :@0.076190:0.396772:0.485140:0.396803:0.485140:0.381020:0.076190:0.380990:0.012413:0.002873:0.004974:0.009071:0.004188:0.002525:0.010205:0.002873:0.010175:0.010160:0.009676:0.004974:0.009676:0.005715:0.004188:0.002525:0.010175:0.009071:0.010205:0.004188:0.002525:0.008225:0.008225:0.004037:0.008225:0.011566:0.004188:0.002525:0.002873:0.009071:0.004188:0.002525:0.004974:0.009071:0.009752:0.005715:0.009676:0.004188:0.002525:0.012413:0.002873:0.004974:0.009071:0.009752:0.009041:0.004974:0.004188:0.002525:0.010175:0.004974:0.004188:0.002525:0.010160:0.010175:0.005715:0.009676:0.002873:0.002873:0.009071:0.009676:0.004188:0.004757:0.329617
4:@0.476092:0.391504:0.480950:0.391504:0.480950:0.382350:0.476092:0.382350:0.004858
Micro-albuminuria  was  associated  with  a  doubling  of :@0.076185:0.411431:0.485080:0.411431:0.485080:0.395648:0.076185:0.395648:0.013743:0.002873:0.009631:0.004400:0.009752:0.004868:0.010175:0.002873:0.010160:0.009041:0.014030:0.002873:0.009071:0.009041:0.004400:0.002873:0.010175:0.004188:0.004067:0.012413:0.010175:0.005715:0.004188:0.004067:0.010175:0.005715:0.005715:0.009752:0.009631:0.002873:0.010175:0.004974:0.009676:0.010205:0.004188:0.004067:0.012413:0.002873:0.004974:0.009071:0.004188:0.004067:0.010175:0.004188:0.004067:0.010205:0.009752:0.009041:0.010160:0.002873:0.002873:0.009071:0.010024:0.004188:0.004067:0.009752:0.004747:0.004188
mortality in all groups, and an 83% increase for the risk :@0.076185:0.426059:0.485125:0.426059:0.485125:0.410276:0.076185:0.410276:0.014030:0.009752:0.004400:0.004974:0.010175:0.002873:0.002873:0.004974:0.007953:0.006078:0.002873:0.009071:0.006078:0.010175:0.002873:0.002873:0.006078:0.010024:0.004400:0.009752:0.009041:0.010160:0.005715:0.004037:0.006078:0.010175:0.009071:0.010205:0.006078:0.010175:0.009071:0.006078:0.008225:0.008225:0.011566:0.006078:0.002873:0.009071:0.009631:0.004400:0.009676:0.010175:0.005715:0.009676:0.006078:0.004596:0.009752:0.004400:0.006078:0.004974:0.009071:0.009676:0.006078:0.004400:0.002873:0.005715:0.007590:0.004188
of myocardial infarction, stroke and heart failure.  Treat-:@0.076185:0.440687:0.480966:0.440697:0.480966:0.424914:0.076185:0.424904:0.009752:0.004596:0.004899:0.014030:0.007953:0.009752:0.009631:0.010175:0.004400:0.010205:0.002873:0.010175:0.002873:0.004899:0.002873:0.009071:0.004596:0.010175:0.004400:0.009631:0.004974:0.002873:0.009752:0.009071:0.004037:0.004899:0.005715:0.004974:0.004400:0.009752:0.007439:0.009676:0.004883:0.010175:0.009071:0.010205:0.004899:0.009071:0.009676:0.010175:0.004400:0.004974:0.004899:0.004596:0.010175:0.002873:0.002873:0.009041:0.004400:0.009676:0.004188:0.004580:0.004899:0.006290:0.004400:0.009676:0.010175:0.004974:0.277141
5:@0.430762:0.435398:0.435620:0.435398:0.435620:0.426244:0.430762:0.426244:0.004858
ment with the ACE inhibitor ramipril resulted in a signifi:@0.076184:0.455325:0.476023:0.455325:0.476023:0.439542:0.076184:0.439542:0.014030:0.009676:0.009071:0.004974:0.005942:0.012413:0.002873:0.004974:0.009071:0.005942:0.004974:0.009071:0.009676:0.005942:0.011037:0.012141:0.007953:0.005942:0.002873:0.009071:0.009071:0.002873:0.010160:0.002873:0.004974:0.009752:0.004400:0.005942:0.004400:0.010175:0.014030:0.002873:0.010160:0.004400:0.002873:0.002873:0.005942:0.004400:0.009676:0.005715:0.009041:0.002873:0.004974:0.009676:0.010205:0.005942:0.002873:0.009071:0.005942:0.010175:0.005942:0.005715:0.002873:0.010024:0.009071:0.002873:0.003606:0.003757
-:@0.475871:0.455325:0.480891:0.455325:0.480891:0.439542:0.475871:0.439542:0.005020
cant reduction in cardiovascular events and mortality, :@0.076184:0.469953:0.485139:0.469953:0.485139:0.454170:0.076184:0.454170:0.009631:0.010175:0.009071:0.004974:0.006516:0.004400:0.009676:0.010205:0.009041:0.009631:0.004974:0.002873:0.009752:0.009071:0.006516:0.002873:0.009071:0.006516:0.009631:0.010175:0.004400:0.010205:0.002873:0.009752:0.008225:0.010175:0.005715:0.009631:0.009041:0.002873:0.010175:0.004400:0.006516:0.009676:0.008225:0.009676:0.009071:0.004974:0.005715:0.006516:0.010175:0.009071:0.010205:0.006516:0.014030:0.009752:0.004400:0.004974:0.010175:0.002873:0.002873:0.004974:0.007953:0.004188:0.004188
particularly in the micro-albuminuria group.  Furthermore, :@0.076184:0.484581:0.485159:0.484591:0.485159:0.468809:0.076184:0.468799:0.010160:0.010175:0.004400:0.004974:0.002873:0.009631:0.009041:0.002873:0.010175:0.004400:0.002873:0.007953:0.003266:0.002873:0.009071:0.003266:0.004974:0.009071:0.009676:0.003266:0.014030:0.002873:0.009631:0.004400:0.009752:0.004868:0.010175:0.002873:0.010160:0.009041:0.014030:0.002873:0.009071:0.009041:0.004400:0.002873:0.010175:0.003266:0.010024:0.004400:0.009752:0.009041:0.010160:0.004188:0.004646:0.003266:0.007182:0.009041:0.004400:0.004974:0.009071:0.009676:0.004400:0.014030:0.009752:0.004400:0.009676:0.004188:0.214636
6:@0.382144:0.479293:0.387002:0.479293:0.387002:0.470139:0.382144:0.470139:0.004858
a meta-analysis of 21 studies done in the general popu-:@0.076189:0.499219:0.480896:0.499219:0.480896:0.483437:0.076189:0.483437:0.010175:0.004762:0.014030:0.009676:0.004974:0.010175:0.004868:0.010175:0.009071:0.010175:0.002873:0.007953:0.005715:0.002873:0.005715:0.004762:0.009752:0.004596:0.004762:0.008225:0.008225:0.004762:0.005715:0.004974:0.009041:0.010205:0.002873:0.009676:0.005715:0.004762:0.010205:0.009752:0.009071:0.009676:0.004762:0.002873:0.009071:0.004762:0.004974:0.009071:0.009676:0.004762:0.010024:0.009676:0.009071:0.009676:0.004400:0.010175:0.002873:0.004762:0.010160:0.009752:0.010160:0.009041:0.005020
lation showed a linear relationship between albuminuria :@0.076189:0.513847:0.485144:0.513847:0.485144:0.498065:0.076189:0.498065:0.002873:0.010175:0.004974:0.002873:0.009752:0.009071:0.004475:0.005715:0.009071:0.009752:0.012413:0.009676:0.010205:0.004475:0.010175:0.004475:0.002873:0.002873:0.009071:0.009676:0.010175:0.004400:0.004475:0.004400:0.009676:0.002873:0.010175:0.004974:0.002873:0.009752:0.009071:0.005715:0.009071:0.002873:0.010160:0.004475:0.010160:0.009676:0.004974:0.012413:0.009676:0.009676:0.009071:0.004475:0.010175:0.002873:0.010160:0.009041:0.014030:0.002873:0.009071:0.009041:0.004400:0.002873:0.010326:0.004188
and cardiovascular mortality.  The reason for this relation-:@0.076189:0.528476:0.480938:0.528486:0.480938:0.512703:0.076189:0.512693:0.010175:0.009071:0.010205:0.003311:0.009631:0.010175:0.004400:0.010205:0.002873:0.009752:0.008225:0.010175:0.005715:0.009631:0.009041:0.002873:0.010175:0.004400:0.003311:0.014030:0.009752:0.004400:0.004974:0.010175:0.002873:0.002873:0.004974:0.007953:0.004188:0.004639:0.003311:0.006290:0.009071:0.009676:0.003311:0.004400:0.009676:0.010175:0.005715:0.009752:0.009071:0.003311:0.004596:0.009752:0.004400:0.003311:0.004974:0.009071:0.002873:0.005715:0.003311:0.004400:0.009676:0.002873:0.010175:0.004974:0.002873:0.009752:0.009071:0.162208
1:@0.285591:0.523187:0.290449:0.523187:0.290449:0.514033:0.285591:0.514033:0.004858
ship is probably the association of micro-albuminuria with :@0.076187:0.543114:0.485096:0.543114:0.485096:0.527331:0.076187:0.527331:0.005715:0.009071:0.002873:0.010160:0.003447:0.002873:0.005715:0.003447:0.010160:0.004400:0.009752:0.010160:0.010175:0.010160:0.002873:0.007953:0.003462:0.004974:0.009071:0.009676:0.003447:0.010175:0.005715:0.005715:0.009752:0.009631:0.002873:0.010175:0.004974:0.002873:0.009752:0.009071:0.003447:0.009752:0.004596:0.003462:0.014030:0.002873:0.009631:0.004400:0.009752:0.004868:0.010175:0.002873:0.010160:0.009041:0.014030:0.002873:0.009071:0.009041:0.004400:0.002873:0.010175:0.003447:0.012413:0.002873:0.004974:0.009223:0.004188
major cardiovascular risk factors – smoking, hypertension, :@0.076187:0.557742:0.485111:0.557742:0.485111:0.541959:0.076187:0.541959:0.014030:0.010175:0.002918:0.009752:0.004400:0.003266:0.009631:0.010175:0.004400:0.010205:0.002873:0.009752:0.008225:0.010175:0.005715:0.009631:0.009041:0.002873:0.010175:0.004400:0.003266:0.004400:0.002873:0.005715:0.007439:0.003266:0.004596:0.010175:0.009631:0.004974:0.009752:0.004400:0.005715:0.003266:0.007408:0.003266:0.005715:0.014030:0.009752:0.007439:0.002873:0.009071:0.010024:0.004037:0.003266:0.009071:0.007953:0.010160:0.009676:0.004400:0.004974:0.009676:0.009071:0.005715:0.002873:0.009752:0.009071:0.004188:0.004188
diabetes, dyslipidaemia and high-sensitivity CRp. Within :@0.076187:0.572370:0.485096:0.572370:0.485096:0.556587:0.076187:0.556587:0.010205:0.002873:0.010175:0.010160:0.009676:0.004974:0.009676:0.005715:0.004037:0.005957:0.010205:0.007953:0.005715:0.002873:0.002873:0.010160:0.002873:0.010205:0.010175:0.009676:0.014030:0.002873:0.010175:0.005957:0.010175:0.009071:0.010205:0.005957:0.009071:0.002873:0.010024:0.009071:0.004868:0.005715:0.009676:0.009071:0.005715:0.002873:0.004974:0.002873:0.008225:0.002873:0.004974:0.007953:0.005957:0.012141:0.009026:0.008799:0.004037:0.005957:0.014363:0.002873:0.004974:0.009071:0.002873:0.009223:0.004188
the hypertensive population, it is a predictor of target or-:@0.076187:0.586998:0.480999:0.586998:0.480999:0.571215:0.076187:0.571215:0.004974:0.009071:0.009676:0.004037:0.009071:0.007953:0.010160:0.009676:0.004400:0.004974:0.009676:0.009071:0.005715:0.002873:0.008225:0.009676:0.004037:0.010160:0.009752:0.010160:0.009041:0.002873:0.010175:0.004974:0.002873:0.009752:0.009071:0.004037:0.004037:0.002873:0.004974:0.004037:0.002873:0.005715:0.004037:0.010175:0.004037:0.010160:0.004400:0.009676:0.010205:0.002873:0.009631:0.004974:0.009752:0.004400:0.004037:0.009752:0.004596:0.004037:0.004974:0.010175:0.004400:0.010024:0.009676:0.004974:0.004037:0.009752:0.004400:0.005020
gan damage, such as left ventricular hypertrophy and in :@0.519038:0.084921:0.927948:0.084921:0.927948:0.069138:0.519038:0.069138:0.010024:0.010175:0.009071:0.003901:0.010205:0.010175:0.014030:0.010175:0.010024:0.009676:0.004037:0.003901:0.005715:0.009041:0.009631:0.009071:0.003901:0.010175:0.005715:0.003901:0.002873:0.009676:0.004596:0.004974:0.003901:0.008225:0.009676:0.009071:0.004974:0.004400:0.002873:0.009631:0.009041:0.002873:0.010175:0.004400:0.003901:0.009071:0.007953:0.010160:0.009676:0.004400:0.004974:0.004400:0.009752:0.010160:0.009071:0.007953:0.003901:0.010175:0.009071:0.010205:0.003901:0.002873:0.009223:0.004188
diabetic incipient kidney disease. :@0.519038:0.099676:0.762545:0.099676:0.762545:0.083893:0.519038:0.083893:0.010205:0.002873:0.010175:0.010160:0.009676:0.004974:0.002873:0.009631:0.004037:0.002873:0.009071:0.009631:0.002873:0.010160:0.002873:0.009676:0.009071:0.004974:0.004037:0.007439:0.002873:0.010205:0.009071:0.009676:0.007953:0.004037:0.010205:0.002873:0.005715:0.009676:0.010175:0.005715:0.009676:0.004188:0.004188
The detection of micro-albuminuria should instigate a full :@0.519038:0.114431:0.927948:0.114431:0.927948:0.098649:0.519038:0.098649:0.006290:0.009071:0.009676:0.003931:0.010205:0.009676:0.004974:0.009676:0.009631:0.004974:0.002873:0.009752:0.009071:0.003931:0.009752:0.004596:0.003931:0.014030:0.002873:0.009631:0.004400:0.009752:0.004868:0.010175:0.002873:0.010160:0.009041:0.014030:0.002873:0.009071:0.009041:0.004400:0.002873:0.010175:0.003931:0.005715:0.009071:0.009752:0.009041:0.002873:0.010205:0.003931:0.002873:0.009071:0.005715:0.004974:0.002873:0.010024:0.010175:0.004974:0.009676:0.003931:0.010175:0.003931:0.004596:0.009041:0.002873:0.003024:0.004188
assessment of the patient for cardiovascular risk (for ex-:@0.519038:0.129186:0.923805:0.129186:0.923805:0.113404:0.519038:0.113404:0.010175:0.005715:0.005715:0.009676:0.005715:0.005715:0.014030:0.009676:0.009071:0.004974:0.005246:0.009752:0.004596:0.005231:0.004974:0.009071:0.009676:0.005246:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.005231:0.004596:0.009752:0.004400:0.005246:0.009631:0.010175:0.004400:0.010205:0.002873:0.009752:0.008225:0.010175:0.005715:0.009631:0.009041:0.002873:0.010175:0.004400:0.005246:0.004400:0.002873:0.005715:0.007439:0.005231:0.005428:0.004596:0.009752:0.004400:0.005231:0.009676:0.007106:0.005020
ample, screening for hypertension, diabetes and dyslipi-:@0.519038:0.143941:0.923820:0.143941:0.923820:0.128159:0.519038:0.128159:0.010175:0.014030:0.010160:0.002873:0.009676:0.004037:0.004657:0.005715:0.009631:0.004400:0.009676:0.009676:0.009071:0.002873:0.009071:0.010024:0.004657:0.004596:0.009752:0.004400:0.004657:0.009071:0.007953:0.010160:0.009676:0.004400:0.004974:0.009676:0.009071:0.005715:0.002873:0.009752:0.009071:0.004037:0.004657:0.010205:0.002873:0.010175:0.010160:0.009676:0.004974:0.009676:0.005715:0.004657:0.010175:0.009071:0.010205:0.004657:0.010205:0.007953:0.005715:0.002873:0.002873:0.010160:0.002873:0.005020
daemia) and underlying kidney disease. The majority of :@0.519038:0.158696:0.927993:0.158696:0.927993:0.142914:0.519038:0.142914:0.010205:0.010175:0.009676:0.014030:0.002873:0.010175:0.005428:0.005095:0.010175:0.009071:0.010205:0.005095:0.009041:0.009071:0.010205:0.009676:0.004400:0.002873:0.007953:0.002873:0.009071:0.010024:0.005095:0.007439:0.002873:0.010205:0.009071:0.009676:0.007953:0.005095:0.010205:0.002873:0.005715:0.009676:0.010175:0.005715:0.009676:0.004037:0.005095:0.006290:0.009071:0.009676:0.005095:0.014030:0.010175:0.002918:0.009752:0.004400:0.002873:0.004974:0.007953:0.005095:0.009752:0.004747:0.004188
patients will have a normal renal function, but in a small :@0.519038:0.173451:0.928023:0.173451:0.928023:0.157669:0.519038:0.157669:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.005715:0.004717:0.012413:0.002873:0.002873:0.002873:0.004717:0.009071:0.010175:0.008225:0.009676:0.004717:0.010175:0.004717:0.009071:0.009752:0.004400:0.014030:0.010175:0.002873:0.004717:0.004400:0.009676:0.009071:0.010175:0.002873:0.004717:0.004596:0.009041:0.009071:0.009631:0.004974:0.002873:0.009752:0.009071:0.004037:0.004717:0.010160:0.009041:0.004974:0.004717:0.002873:0.009071:0.004717:0.010175:0.004717:0.005715:0.014030:0.010175:0.002873:0.003024:0.004188
percentage, the eGFR will be below 60 ml/min, and this :@0.519038:0.188207:0.928023:0.188207:0.928023:0.172424:0.519038:0.172424:0.010160:0.009676:0.004400:0.009631:0.009676:0.009071:0.004974:0.010175:0.010024:0.009676:0.004037:0.004762:0.004974:0.009071:0.009676:0.004762:0.009676:0.013033:0.007182:0.009026:0.004762:0.012413:0.002873:0.002873:0.002873:0.004762:0.010160:0.009676:0.004762:0.010160:0.009676:0.002873:0.009752:0.012413:0.004762:0.008225:0.008225:0.004762:0.014030:0.002873:0.006456:0.014030:0.002873:0.009071:0.004037:0.004762:0.010175:0.009071:0.010205:0.004762:0.004974:0.009071:0.002873:0.005866:0.004188
should prompt referral to a specialist (see Figure 1).:@0.519038:0.202962:0.882757:0.202962:0.882757:0.187179:0.519038:0.187179:0.005715:0.009071:0.009752:0.009041:0.002873:0.010205:0.004037:0.010160:0.004400:0.009752:0.014030:0.010160:0.004974:0.004037:0.004400:0.009676:0.004596:0.009676:0.004400:0.004400:0.010175:0.002873:0.004037:0.004974:0.009752:0.004037:0.010175:0.004037:0.005715:0.010160:0.009676:0.009631:0.002873:0.010175:0.002873:0.002873:0.005715:0.004974:0.004037:0.005428:0.005715:0.009676:0.009676:0.004037:0.007182:0.002873:0.010024:0.009041:0.004400:0.009676:0.004037:0.008225:0.005428:0.004188
In those with normal kidney function, the general prac-:@0.533326:0.217717:0.923790:0.217717:0.923790:0.201934:0.533326:0.201934:0.003417:0.009223:0.002888:0.005125:0.009223:0.009903:0.005866:0.009827:0.002888:0.012564:0.003024:0.005125:0.009223:0.002888:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.002888:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.002888:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.002873:0.005125:0.009223:0.009827:0.002888:0.010175:0.009827:0.009223:0.009827:0.004551:0.010326:0.003024:0.002888:0.010311:0.004551:0.010326:0.009782:0.005020
titioner should focus on prevention of cardiovascular risk :@0.519038:0.232472:0.927978:0.232472:0.927978:0.216689:0.519038:0.216689:0.005125:0.003024:0.005125:0.003024:0.009903:0.009223:0.009827:0.004551:0.003462:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.003477:0.004747:0.009903:0.009782:0.009192:0.005866:0.003477:0.009903:0.009223:0.003477:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.003462:0.009903:0.004747:0.003477:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.003477:0.004551:0.003024:0.005866:0.007590:0.004188
through lifestyle changes, especially stopping smoking :@0.519038:0.247227:0.927993:0.247227:0.927993:0.231444:0.519038:0.231444:0.005125:0.009223:0.004551:0.009903:0.009192:0.010175:0.009223:0.005821:0.003024:0.003024:0.004747:0.009827:0.005866:0.005125:0.008104:0.003024:0.009827:0.005836:0.009782:0.009223:0.010326:0.009223:0.010175:0.009827:0.005866:0.004188:0.005836:0.009827:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.008104:0.005851:0.005866:0.005125:0.009903:0.010311:0.010311:0.003024:0.009223:0.010175:0.005836:0.005866:0.014182:0.009903:0.007590:0.003024:0.009223:0.010175:0.004188
and pharmacological treatment. The Bp should be tar-:@0.519038:0.261982:0.923790:0.261982:0.923790:0.246199:0.519038:0.246199:0.010326:0.009223:0.010357:0.004808:0.010311:0.009223:0.010326:0.004551:0.014182:0.010326:0.009782:0.009903:0.003024:0.009903:0.010175:0.003024:0.009782:0.010326:0.003024:0.004808:0.005125:0.004551:0.009827:0.010326:0.005125:0.014167:0.009827:0.009223:0.005125:0.004188:0.004808:0.006441:0.009223:0.009827:0.004808:0.008678:0.008950:0.004808:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004808:0.010311:0.009827:0.004808:0.005125:0.010326:0.004551:0.005020
geted to <140/90 mmHg, according to the South Afri:@0.519038:0.276737:0.918801:0.276737:0.918801:0.260954:0.519038:0.260954:0.010175:0.009827:0.005125:0.009827:0.010357:0.005987:0.005125:0.009903:0.005987:0.009162:0.008376:0.008376:0.008376:0.006607:0.008376:0.008376:0.006002:0.014182:0.014182:0.010326:0.010175:0.004188:0.005987:0.010326:0.009782:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.005987:0.005125:0.009903:0.005987:0.005125:0.009223:0.009827:0.005987:0.007529:0.009903:0.009192:0.005125:0.009223:0.005987:0.011188:0.004747:0.004551:0.003024
-:@0.918801:0.276737:0.923820:0.276737:0.923820:0.260954:0.918801:0.260954:0.005020
can Hypertension Guidelines.  Other guidelines suggest :@0.519038:0.291492:0.927991:0.291539:0.927991:0.275757:0.519038:0.275710:0.009782:0.010326:0.009223:0.004581:0.010326:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004581:0.013184:0.009192:0.003024:0.010357:0.009827:0.003024:0.003024:0.009223:0.009827:0.005866:0.004188:0.004867:0.004581:0.013138:0.005125:0.009223:0.009827:0.004551:0.004566:0.010175:0.009192:0.003024:0.010357:0.009827:0.003024:0.003024:0.009223:0.009827:0.005866:0.004581:0.005866:0.009192:0.010175:0.010175:0.009827:0.005866:0.005125:0.024610
7:@0.733584:0.286241:0.738442:0.286241:0.738442:0.277087:0.733584:0.277087:0.004858
<130/80  mmHg,  if  well  tolerated.:@0.519052:0.306294:0.770088:0.306294:0.770088:0.290512:0.519052:0.290512:0.009162:0.008376:0.008376:0.008376:0.006607:0.008376:0.008376:0.004188:0.003795:0.014182:0.014182:0.010326:0.010175:0.004188:0.004188:0.003765:0.003024:0.004747:0.004188:0.003780:0.012564:0.009827:0.003024:0.003024:0.004188:0.003780:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.005125:0.009827:0.010357:0.004188
8:@0.770067:0.300998:0.774925:0.300998:0.774925:0.291844:0.770067:0.291844:0.004858
 ACEi/ARBs are  the :@0.774927:0.306297:0.928007:0.306297:0.928007:0.290514:0.774927:0.290514:0.007968:0.011188:0.012292:0.008104:0.003024:0.006607:0.011188:0.009177:0.008678:0.005866:0.007968:0.010326:0.004551:0.009827:0.004188:0.003765:0.005125:0.009223:0.009827:0.004188
preferred drugs of choice, but in diabetics ACEi/ARBs :@0.519052:0.321052:0.928007:0.321052:0.928007:0.305269:0.519052:0.305269:0.010311:0.004551:0.009827:0.004747:0.009827:0.004551:0.004551:0.009827:0.010357:0.006426:0.010357:0.004551:0.009192:0.010175:0.005866:0.006441:0.009903:0.004747:0.006441:0.009782:0.009223:0.009903:0.003024:0.009782:0.009827:0.004188:0.006426:0.010311:0.009192:0.005125:0.006441:0.003024:0.009223:0.006441:0.010357:0.003024:0.010326:0.010311:0.009827:0.005125:0.003024:0.009782:0.005866:0.006441:0.011188:0.012292:0.008104:0.003024:0.006607:0.011188:0.009177:0.008678:0.005866:0.004188
are compelling indications for  treatment  as they pre-:@0.519052:0.335807:0.923819:0.335807:0.923819:0.320024:0.519052:0.320024:0.010326:0.004551:0.009827:0.006864:0.009782:0.009903:0.014182:0.010311:0.009827:0.003024:0.003024:0.003024:0.009223:0.010175:0.006864:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.006864:0.004747:0.009903:0.004551:0.004188:0.002661:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.002661:0.010326:0.005866:0.006864:0.005125:0.009223:0.009827:0.008104:0.006864:0.010311:0.004551:0.009827:0.005020
vent both progression of diabetic kidney disease, and :@0.519052:0.350562:0.928007:0.350562:0.928007:0.334780:0.519052:0.334780:0.008376:0.009827:0.009223:0.005125:0.005821:0.010311:0.009903:0.005125:0.009223:0.005806:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.005821:0.009903:0.004747:0.005806:0.010357:0.003024:0.010326:0.010311:0.009827:0.005125:0.003024:0.009782:0.005821:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.005821:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.005821:0.010326:0.009223:0.010357:0.004188
lower  cardiovascular events and mortality (especially :@0.519052:0.365317:0.927992:0.365317:0.927992:0.349535:0.519052:0.349535:0.003024:0.009903:0.012564:0.009827:0.004551:0.004188:0.002857:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.007061:0.009827:0.008376:0.009827:0.009223:0.005125:0.005866:0.007061:0.010326:0.009223:0.010357:0.007061:0.014182:0.009903:0.004551:0.005125:0.010326:0.003024:0.003024:0.005125:0.008104:0.007061:0.005579:0.009827:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.008104:0.004188
with ACEi). The LDL cholesterol should be targeted to :@0.519052:0.380072:0.927992:0.380072:0.927992:0.364290:0.519052:0.364290:0.012564:0.003024:0.005125:0.009223:0.006456:0.011188:0.012292:0.008104:0.003024:0.005579:0.004188:0.006456:0.006441:0.009223:0.009827:0.006456:0.006985:0.011249:0.006985:0.006456:0.009782:0.009223:0.009903:0.003024:0.009827:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.006456:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.006456:0.010311:0.009827:0.006456:0.005125:0.010326:0.004551:0.010175:0.009827:0.005125:0.009827:0.010357:0.006441:0.005125:0.009903:0.004188
<1.8  mmol/L  with  the  use  of  statins,  according  to  the :@0.519052:0.394827:0.928007:0.394827:0.928007:0.379045:0.519052:0.379045:0.009162:0.008376:0.004188:0.008376:0.004188:0.002600:0.014182:0.014182:0.009903:0.003024:0.006607:0.006985:0.004188:0.002600:0.012564:0.003024:0.005125:0.009223:0.004188:0.002600:0.005125:0.009223:0.009827:0.004188:0.002585:0.009192:0.005866:0.009827:0.004188:0.002600:0.009903:0.004747:0.004188:0.002600:0.005866:0.005125:0.010326:0.005125:0.003024:0.009223:0.005866:0.004188:0.004188:0.002600:0.010326:0.009782:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.004188:0.002585:0.005125:0.009903:0.004188:0.002600:0.005125:0.009223:0.009827:0.004188
south Africa Lipid Guidelines.  Diabetic control needs to :@0.519052:0.409582:0.928000:0.409601:0.928000:0.393818:0.519052:0.393800:0.007529:0.009903:0.009192:0.005125:0.009223:0.003795:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.003795:0.006985:0.003024:0.010311:0.003024:0.010357:0.003810:0.013184:0.009192:0.003024:0.010357:0.009827:0.003024:0.003024:0.009223:0.009827:0.005866:0.004188:0.004846:0.003795:0.011249:0.003024:0.010326:0.010311:0.009827:0.005125:0.003024:0.009782:0.003810:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.003780:0.009223:0.009827:0.009827:0.010357:0.005866:0.003795:0.005125:0.009903:-0.130003
9:@0.729465:0.404302:0.734323:0.404302:0.734323:0.395148:0.729465:0.395148:0.004858
be optimised, according to the society for Endocrinol-:@0.519045:0.424356:0.923812:0.424356:0.923812:0.408573:0.519045:0.408573:0.010311:0.009827:0.005413:0.009903:0.010311:0.005125:0.003024:0.014182:0.003024:0.005866:0.009827:0.010357:0.004188:0.005413:0.010326:0.009782:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.005413:0.005125:0.009903:0.005413:0.005125:0.009223:0.009827:0.005413:0.007529:0.009903:0.009782:0.003024:0.009827:0.005125:0.008104:0.005413:0.004747:0.009903:0.004551:0.005413:0.008104:0.009223:0.010357:0.009903:0.009782:0.004551:0.003024:0.009223:0.009903:0.003024:0.005020
ogy Metabolism  Diabetes  of  south Africa Guidelines  :@0.519045:0.439111:0.927997:0.439116:0.927997:0.423334:0.519045:0.423328:0.009903:0.010175:0.008104:0.006667:0.013894:0.009827:0.005125:0.010326:0.010311:0.009903:0.003024:0.003024:0.005866:0.014182:0.004188:0.002495:0.011249:0.003024:0.010326:0.010311:0.009827:0.005125:0.009827:0.005866:0.004188:0.002495:0.009903:0.004747:0.004188:0.002480:0.007529:0.009903:0.009192:0.005125:0.009223:0.006667:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.006667:0.013184:0.009192:0.003024:0.010357:0.009827:0.003024:0.003024:0.009223:0.009827:0.005866:0.009719:-0.168651
10:@0.914089:0.433818:0.923805:0.433818:0.923805:0.424664:0.914089:0.424664:0.004858:0.004858
and consideration given to sGLUT-2 inhibitors that are :@0.519042:0.453871:0.927997:0.453871:0.927997:0.438089:0.519042:0.438089:0.010326:0.009223:0.010357:0.006274:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.006259:0.010175:0.003024:0.008376:0.009827:0.009223:0.006274:0.005125:0.009903:0.006259:0.007529:0.013184:0.006985:0.009903:0.006441:0.005020:0.008376:0.006259:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.006274:0.005125:0.009223:0.010326:0.005125:0.006259:0.010326:0.004551:0.009827:0.004188
now shown to prevent progression of chronic kidney dis-:@0.519042:0.468626:0.923809:0.468626:0.923809:0.452844:0.519042:0.452844:0.009223:0.009903:0.012564:0.003538:0.005866:0.009223:0.009903:0.012564:0.009223:0.003538:0.005125:0.009903:0.003538:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.003538:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.003538:0.009903:0.004747:0.003538:0.009782:0.009223:0.004551:0.009903:0.009223:0.003024:0.009782:0.003538:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.003538:0.010357:0.003024:0.005866:0.005020
ease in diabetics.:@0.519042:0.483381:0.647342:0.483381:0.647342:0.467599:0.519042:0.467599:0.009827:0.010326:0.005866:0.009827:0.004188:0.003024:0.009223:0.004188:0.010357:0.003024:0.010326:0.010311:0.009827:0.005125:0.003024:0.009782:0.005866:0.004188
11:@0.647352:0.478091:0.657068:0.478091:0.657068:0.468937:0.647352:0.468937:0.004858:0.004858
The ACR should be monitored, and if normalised, it is :@0.533333:0.498147:0.927985:0.498147:0.927985:0.482364:0.533333:0.482364:0.006441:0.009223:0.009827:0.005004:0.011188:0.012292:0.009177:0.005020:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005020:0.010311:0.009827:0.005020:0.014182:0.009903:0.009223:0.003024:0.005125:0.009903:0.004551:0.009827:0.010357:0.004188:0.005004:0.010326:0.009223:0.010357:0.005020:0.003024:0.004747:0.005020:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.003024:0.005866:0.009827:0.010357:0.004188:0.005020:0.003024:0.005125:0.005020:0.003024:0.005866:0.004188
associated with improvement in both renal and cardio-:@0.519045:0.512902:0.923827:0.512902:0.923827:0.497119:0.519045:0.497119:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.004188:0.012564:0.003024:0.005125:0.009223:0.004188:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188:0.003024:0.009223:0.004188:0.010311:0.009903:0.005125:0.009223:0.004173:0.004551:0.009827:0.009223:0.010326:0.003024:0.004173:0.010326:0.009223:0.010357:0.004188:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.005020
vascular outcomes. If the ACR increases despite these :@0.519045:0.527657:0.927985:0.527657:0.927985:0.511874:0.519045:0.511874:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.005413:0.009903:0.009192:0.005125:0.009782:0.009903:0.014182:0.009827:0.005866:0.004188:0.005397:0.003417:0.004747:0.005413:0.005125:0.009223:0.009827:0.005397:0.011188:0.012292:0.009177:0.005397:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.005866:0.005413:0.010357:0.009827:0.005866:0.010311:0.003024:0.005125:0.009827:0.005413:0.005125:0.009223:0.009827:0.005866:0.009827:0.004188
measures, a referral is warranted.:@0.519045:0.542412:0.761283:0.542412:0.761283:0.526630:0.519045:0.526630:0.014182:0.009827:0.010326:0.005866:0.009192:0.004551:0.009827:0.005866:0.004188:0.004188:0.010326:0.004188:0.004551:0.009827:0.004747:0.009827:0.004551:0.004551:0.010326:0.003024:0.004188:0.003024:0.005866:0.004188:0.012564:0.010326:0.004551:0.004551:0.010326:0.009223:0.005125:0.009827:0.010357:0.004188
macro-albuminuria:@0.519047:0.574248:0.675949:0.574248:0.675949:0.555917:0.519047:0.555917:0.015119:0.011087:0.010751:0.005376:0.010751:0.007056:0.011087:0.004032:0.011087:0.010079:0.015791:0.004032:0.010079:0.010079:0.005376:0.004032:0.011087
Macro-albuminuria  has  been  defined  as  an  ACR :@0.519047:0.591178:0.927987:0.591178:0.927987:0.575395:0.519047:0.575395:0.013894:0.010326:0.009782:0.004551:0.009903:0.005020:0.010326:0.003024:0.010311:0.009192:0.014182:0.003024:0.009223:0.009192:0.004551:0.003024:0.010326:0.004188:0.008300:0.009223:0.010326:0.005866:0.004188:0.008300:0.010311:0.009827:0.009827:0.009223:0.004188:0.008300:0.010357:0.009827:0.003681:0.003681:0.009223:0.009827:0.010357:0.004188:0.008300:0.010326:0.005866:0.004188:0.008315:0.010326:0.009223:0.004188:0.008300:0.011188:0.012292:0.009177:0.004188
>30 mgm/mmol and defines the presence of overt kid:@0.519047:0.605933:0.918795:0.605933:0.918795:0.590150:0.519047:0.590150:0.009162:0.008376:0.008376:0.004793:0.014182:0.010175:0.014182:0.006607:0.014182:0.014182:0.009903:0.003024:0.004778:0.010326:0.009223:0.010357:0.004778:0.010357:0.009827:0.003681:0.003681:0.009223:0.009827:0.005866:0.004778:0.005125:0.009223:0.009827:0.004778:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.009782:0.009827:0.004778:0.009903:0.004747:0.004778:0.009903:0.008376:0.009827:0.004551:0.005125:0.004778:0.007590:0.003024:0.010357
-:@0.918795:0.605933:0.923814:0.605933:0.923814:0.590150:0.918795:0.590150:0.005020
ney disease. The author has arbitrarily classified macro-:@0.519047:0.620688:0.923814:0.620688:0.923814:0.604905:0.519047:0.604905:0.009223:0.009827:0.008104:0.004717:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.004717:0.006441:0.009223:0.009827:0.004702:0.010326:0.009192:0.005125:0.009223:0.009903:0.004551:0.004702:0.009223:0.010326:0.005866:0.004717:0.010326:0.004551:0.010311:0.003024:0.005125:0.004551:0.010326:0.004551:0.003024:0.003024:0.008104:0.004717:0.009782:0.003024:0.010326:0.005866:0.005866:0.003024:0.003681:0.003681:0.009827:0.010357:0.004717:0.014182:0.010326:0.009782:0.004551:0.009903:0.005020
albuminuria into mild (30-70  mgm/mmol), moderate :@0.519047:0.635443:0.928002:0.635443:0.928002:0.619660:0.519047:0.619660:0.010326:0.003024:0.010311:0.009192:0.014182:0.003024:0.009223:0.009192:0.004551:0.003024:0.010326:0.009223:0.003024:0.009223:0.005125:0.009903:0.009223:0.014182:0.003024:0.003024:0.010357:0.009223:0.005579:0.008376:0.008376:0.005020:0.008376:0.008391:0.004188:0.005035:0.014182:0.010175:0.014182:0.006607:0.014182:0.014182:0.009903:0.003024:0.005579:0.004188:0.009223:0.014182:0.009903:0.010357:0.009827:0.004551:0.010326:0.005125:0.009827:0.004188
(70-200  mgm/mmol) and severe (>200  mgm/mmol) :@0.519047:0.650198:0.928002:0.650198:0.928002:0.634416:0.519047:0.634416:0.005579:0.008376:0.008376:0.005020:0.008376:0.008376:0.008376:0.004188:0.005866:0.014182:0.010175:0.014182:0.006607:0.014182:0.014182:0.009903:0.003024:0.005579:0.010039:0.010326:0.009223:0.010357:0.010039:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.010039:0.005579:0.009162:0.008376:0.008376:0.008376:0.004188:0.005851:0.014182:0.010175:0.014182:0.006607:0.014182:0.014182:0.009903:0.003024:0.005579:0.004188
(see Table 1). Common causes of kidney disease in rela-:@0.519047:0.664953:0.923814:0.664953:0.923814:0.649171:0.519047:0.649171:0.005579:0.005866:0.009827:0.009827:0.003583:0.006441:0.010326:0.010311:0.003024:0.009827:0.003568:0.008376:0.005579:0.004188:0.003583:0.012292:0.009903:0.014182:0.014182:0.009903:0.009223:0.003568:0.009782:0.010326:0.009192:0.005866:0.009827:0.005866:0.003583:0.009903:0.004747:0.003568:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.003583:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.003583:0.003024:0.009223:0.003568:0.004551:0.009827:0.003024:0.010326:0.005020
tion to albuminuria are shown in Table 1. patients with :@0.519047:0.679708:0.928002:0.679708:0.928002:0.663926:0.519047:0.663926:0.005125:0.003024:0.009903:0.009223:0.005821:0.005125:0.009903:0.005821:0.010326:0.003024:0.010311:0.009192:0.014182:0.003024:0.009223:0.009192:0.004551:0.003024:0.010326:0.005836:0.010326:0.004551:0.009827:0.005821:0.005866:0.009223:0.009903:0.012564:0.009223:0.005836:0.003024:0.009223:0.005836:0.006441:0.010326:0.010311:0.003024:0.009827:0.005836:0.008376:0.004188:0.005836:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005821:0.012564:0.003024:0.005125:0.009223:0.004188
severe macro-albuminuria are also likely to have under-:@0.519047:0.694463:0.923814:0.694463:0.923814:0.678681:0.519047:0.678681:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.003855:0.014182:0.010326:0.009782:0.004551:0.009903:0.005020:0.010326:0.003024:0.010311:0.009192:0.014182:0.003024:0.009223:0.009192:0.004551:0.003024:0.010326:0.003855:0.010326:0.004551:0.009827:0.003855:0.010326:0.003024:0.005866:0.009903:0.003855:0.003024:0.003024:0.007590:0.009827:0.003024:0.008104:0.003870:0.005125:0.009903:0.003855:0.009223:0.010326:0.008376:0.009827:0.003855:0.009192:0.009223:0.010357:0.009827:0.004536:0.005020
lying nephrotic syndrome, i.e. the additional presence :@0.519047:0.709219:0.928017:0.709219:0.928017:0.693436:0.519047:0.693436:0.003024:0.008104:0.003024:0.009223:0.010175:0.005791:0.009223:0.009827:0.010311:0.009223:0.004551:0.009903:0.005125:0.003024:0.009782:0.005791:0.005866:0.008104:0.009223:0.010357:0.004551:0.009903:0.014182:0.009827:0.004188:0.005791:0.003024:0.004188:0.009827:0.004188:0.005791:0.005125:0.009223:0.009827:0.005791:0.010326:0.010357:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.005806:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.009782:0.009827:0.004188
of oedema, high cholesterol and hypo-albuminaemia. :@0.519047:0.723974:0.922756:0.723974:0.922756:0.708191:0.519047:0.708191:0.009903:0.004747:0.004188:0.009903:0.009827:0.010357:0.009827:0.014182:0.010326:0.004188:0.004188:0.009223:0.003024:0.010175:0.009223:0.004188:0.009782:0.009223:0.009903:0.003024:0.009827:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.004188:0.010326:0.009223:0.010357:0.004188:0.009223:0.008104:0.010311:0.009903:0.005020:0.010326:0.003024:0.010311:0.009192:0.014182:0.003024:0.009223:0.010326:0.009827:0.014182:0.003024:0.010326:0.004188:0.004188
These patients are at even higher risk of progression :@0.533335:0.738729:0.927987:0.738729:0.927987:0.722946:0.533335:0.722946:0.006441:0.009223:0.009827:0.005866:0.009827:0.006017:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006017:0.010326:0.004551:0.009827:0.006017:0.010326:0.005125:0.006017:0.009827:0.008376:0.009827:0.009223:0.006017:0.009223:0.003024:0.010175:0.009223:0.009827:0.004551:0.006017:0.004551:0.003024:0.005866:0.007590:0.006017:0.009903:0.004747:0.006017:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.004188
of kidney disease and cardiovascular events. The ap-:@0.519047:0.753484:0.923799:0.753484:0.923799:0.737701:0.519047:0.737701:0.009903:0.004747:0.006290:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.006290:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.006290:0.010326:0.009223:0.010357:0.006290:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.006290:0.009827:0.008376:0.009827:0.009223:0.005125:0.005866:0.004188:0.006290:0.006441:0.009223:0.009827:0.006274:0.010326:0.010311:0.005020
proach  is very  similar to  that  described under  micro-:@0.519047:0.768239:0.923814:0.768239:0.923814:0.752456:0.519047:0.752456:0.010311:0.004551:0.009903:0.010326:0.009782:0.009223:0.004188:0.003130:0.003024:0.005866:0.007333:0.008376:0.009827:0.004551:0.008104:0.004188:0.003130:0.005866:0.003024:0.014182:0.003024:0.003024:0.010326:0.004551:0.007333:0.005125:0.009903:0.004188:0.003130:0.005125:0.009223:0.010326:0.005125:0.004188:0.003130:0.010357:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.010357:0.007333:0.009192:0.009223:0.010357:0.009827:0.004551:0.004188:0.003130:0.014182:0.003024:0.009782:0.004551:0.009903:0.005020
albuminuria. ACEi/ARBs are mandatory to lower albu-:@0.519047:0.782994:0.923799:0.782994:0.923799:0.767211:0.519047:0.767211:0.010326:0.003024:0.010311:0.009192:0.014182:0.003024:0.009223:0.009192:0.004551:0.003024:0.010326:0.004188:0.006426:0.011188:0.012292:0.008104:0.003024:0.006607:0.011188:0.009177:0.008678:0.005866:0.006426:0.010326:0.004551:0.009827:0.006410:0.014182:0.010326:0.009223:0.010357:0.010326:0.005125:0.009903:0.004551:0.008104:0.006410:0.005125:0.009903:0.006410:0.003024:0.009903:0.012564:0.009827:0.004551:0.006410:0.010326:0.003024:0.010311:0.009192:0.005020
minuria and prevent the progression of kidney disease :@0.519047:0.797749:0.927987:0.797749:0.927987:0.781966:0.519047:0.781966:0.014182:0.003024:0.009223:0.009192:0.004551:0.003024:0.010326:0.005549:0.010326:0.009223:0.010357:0.005549:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.005549:0.005125:0.009223:0.009827:0.005549:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.009903:0.009223:0.005549:0.009903:0.004747:0.005549:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.005549:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188
unless contra-indicated.  sGLUT-2 inhibitors should also :@0.519047:0.812504:0.928002:0.812504:0.928002:0.796721:0.519047:0.796721:0.009192:0.009223:0.003024:0.009827:0.005866:0.005866:0.007045:0.009782:0.009903:0.009223:0.005125:0.004551:0.010326:0.005020:0.003024:0.009207:0.010357:0.003024:0.009782:0.010326:0.005125:0.009827:0.010357:0.004188:0.004188:0.002857:0.007529:0.013184:0.006985:0.009903:0.006441:0.005020:0.008376:0.007045:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.007045:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.007045:0.010326:0.003024:0.005866:0.009903:0.004188
be considered in diabetics unless the eGFR is <30 ml/min. :@0.519047:0.827259:0.928002:0.827259:0.928002:0.811477:0.519047:0.811477:0.010311:0.009827:0.002903:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.009827:0.010357:0.002888:0.003024:0.009223:0.002903:0.010357:0.003024:0.010326:0.010311:0.009827:0.005125:0.003024:0.009782:0.005866:0.002903:0.009192:0.009223:0.003024:0.009827:0.005866:0.005866:0.002903:0.005125:0.009223:0.009827:0.002888:0.009827:0.013184:0.007333:0.009177:0.002888:0.003024:0.005866:0.002903:0.009162:0.008376:0.008376:0.002918:0.014182:0.003024:0.006607:0.014182:0.003024:0.009223:0.004188:0.004188
Cardiovascular protection  should  focus  on  lifestyle :@0.519047:0.842014:0.927972:0.842014:0.927972:0.826232:0.519047:0.826232:0.012292:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.011475:0.010311:0.004551:0.009903:0.005125:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.007272:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004188:0.007272:0.004747:0.009903:0.009782:0.009192:0.005866:0.004188:0.007272:0.009903:0.009223:0.004188:0.007272:0.003024:0.003024:0.004747:0.009827:0.005866:0.005125:0.008104:0.003024:0.009827:0.004188
changes, lowering Bp and LDL cholesterol to target and :@0.519047:0.856769:0.927972:0.856769:0.927972:0.840987:0.519047:0.840987:0.009782:0.009223:0.010326:0.009223:0.010175:0.009827:0.005866:0.004188:0.003870:0.003024:0.009903:0.012564:0.009827:0.004551:0.003024:0.009223:0.010175:0.003870:0.008678:0.008950:0.003870:0.010326:0.009223:0.010357:0.003870:0.006985:0.011249:0.006985:0.003870:0.009782:0.009223:0.009903:0.003024:0.009827:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.003870:0.005125:0.009903:0.003870:0.005125:0.010326:0.004551:0.010175:0.009827:0.005125:0.003870:0.010326:0.009223:0.010357:0.004188
optimise diabetic control.:@0.519047:0.871524:0.706161:0.871524:0.706161:0.855742:0.519047:0.855742:0.009903:0.010311:0.005125:0.003024:0.014182:0.003024:0.005866:0.009827:0.004188:0.010357:0.003024:0.010326:0.010311:0.009827:0.005125:0.003024:0.009782:0.004188:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.004188
All patients with moderate to severe macro-albuminuria :@0.533335:0.886280:0.927987:0.886280:0.927987:0.870497:0.533335:0.870497:0.010886:0.002721:0.002721:0.003523:0.010009:0.010024:0.004823:0.002721:0.009525:0.008920:0.004823:0.005564:0.003523:0.012262:0.002721:0.004823:0.008920:0.003523:0.013879:0.009601:0.010054:0.009525:0.004248:0.010024:0.004823:0.009525:0.003523:0.004823:0.009601:0.003523:0.005564:0.009525:0.008074:0.009525:0.004248:0.009525:0.003523:0.013879:0.010024:0.009480:0.004248:0.009601:0.004717:0.010024:0.002721:0.010009:0.008890:0.013879:0.002721:0.008920:0.008890:0.004248:0.002721:0.010326:0.004188
should be referred for specialist treatment. patients with :@0.519047:0.901035:0.928047:0.901035:0.928047:0.885252:0.519047:0.885252:0.005564:0.008920:0.009601:0.008890:0.002721:0.010054:0.006244:0.010009:0.009525:0.006244:0.004248:0.009525:0.004445:0.009525:0.004248:0.004248:0.009525:0.010054:0.006244:0.004445:0.009601:0.004248:0.006244:0.005564:0.010009:0.009525:0.009480:0.002721:0.010024:0.002721:0.002721:0.005564:0.004823:0.006244:0.004823:0.004248:0.009525:0.010024:0.004823:0.013879:0.009525:0.008920:0.004823:0.003886:0.006244:0.008648:0.010024:0.004823:0.002721:0.009525:0.008920:0.004823:0.005564:0.006244:0.012262:0.002721:0.004823:0.009223:0.004188
mild macro-albuminuria can be handled by experienced :@0.519047:0.915790:0.927972:0.915790:0.927972:0.900007:0.519047:0.900007:0.013879:0.002721:0.002721:0.010054:0.003931:0.013879:0.010024:0.009480:0.004248:0.009601:0.004717:0.010024:0.002721:0.010009:0.008890:0.013879:0.002721:0.008920:0.008890:0.004248:0.002721:0.010024:0.003931:0.009480:0.010024:0.008920:0.003931:0.010009:0.009525:0.003931:0.008920:0.010024:0.008920:0.010054:0.002721:0.009525:0.010054:0.003931:0.010009:0.007801:0.003931:0.009525:0.006955:0.010009:0.009525:0.004248:0.002721:0.009525:0.008920:0.009480:0.009525:0.010357:0.004188
general practitioners as outlined, but if the eGFR is <60 ml/:@0.519047:0.930545:0.923799:0.930545:0.923799:0.914762:0.519047:0.914762:0.009873:0.009525:0.008920:0.009525:0.004248:0.010024:0.002721:0.003750:0.010009:0.004248:0.010024:0.009480:0.004823:0.002721:0.004823:0.002721:0.009601:0.008920:0.009525:0.004248:0.005564:0.003750:0.010024:0.005564:0.003750:0.009601:0.008890:0.004823:0.002721:0.002721:0.008920:0.009525:0.010054:0.003886:0.003750:0.010009:0.008890:0.004823:0.003750:0.002721:0.004445:0.003750:0.004823:0.008920:0.009525:0.003750:0.009525:0.012881:0.007030:0.008875:0.003750:0.002721:0.005564:0.003750:0.008860:0.008074:0.008074:0.003765:0.013879:0.002721:0.006607
min, referral is recommended for further evaluation.:@0.519047:0.945300:0.880634:0.945300:0.880634:0.929517:0.519047:0.929517:0.013879:0.002721:0.008920:0.003886:0.003886:0.004248:0.009525:0.004445:0.009525:0.004248:0.004248:0.010024:0.002721:0.003886:0.002721:0.005564:0.003886:0.004248:0.009525:0.009480:0.009601:0.013879:0.013879:0.009525:0.008920:0.010054:0.009525:0.010054:0.003886:0.004445:0.009601:0.004248:0.003886:0.004445:0.008890:0.004248:0.004823:0.008920:0.009525:0.004248:0.003886:0.009525:0.008074:0.010024:0.002721:0.008890:0.010024:0.004823:0.002721:0.009601:0.008920:0.004188
 :@0.171143:0.611936:0.173720:0.611936:0.173720:0.602299:0.171143:0.602299:0.002577
Persistent albuminuria categories:@0.322523:0.615583:0.472193:0.615583:0.472193:0.605473:0.322523:0.605473:0.006230:0.005118:0.003681:0.005118:0.002559:0.005276:0.003041:0.005276:0.005591:0.003041:0.002717:0.005118:0.002717:0.005591:0.005591:0.008316:0.002717:0.005758:0.005591:0.003681:0.002559:0.005118:0.002717:0.005118:0.005118:0.003199:0.005276:0.005591:0.005591:0.003672:0.002717:0.005118:0.005155
 :@0.472305:0.615223:0.474883:0.615223:0.474883:0.605586:0.472305:0.605586:0.002577
Description and range:@0.353375:0.624104:0.451736:0.624104:0.451736:0.613994:0.353375:0.613994:0.006713:0.005118:0.005118:0.005118:0.003681:0.002717:0.005591:0.003199:0.002559:0.005758:0.005591:0.002717:0.005118:0.005758:0.005591:0.002559:0.003681:0.005276:0.005591:0.005758:0.005155
 :@0.451844:0.623744:0.454422:0.623744:0.454422:0.614107:0.451844:0.614107:0.002577
A1:@0.295508:0.635308:0.306736:0.635308:0.306736:0.625671:0.295508:0.625671:0.006073:0.005155
 :@0.306698:0.635308:0.309275:0.635308:0.309275:0.625671:0.306698:0.625671:0.002577
A2:@0.365524:0.635308:0.376751:0.635308:0.376751:0.625671:0.365524:0.625671:0.006073:0.005155
 :@0.376713:0.635308:0.379291:0.635308:0.379291:0.625671:0.376713:0.625671:0.002577
A3:@0.436498:0.635308:0.447884:0.635308:0.447884:0.625671:0.436498:0.625671:0.006230:0.005155
 :@0.447848:0.635308:0.450425:0.635308:0.450425:0.625671:0.447848:0.625671:0.002577
Normal to :@0.278724:0.652472:0.319346:0.652472:0.319346:0.642835:0.278724:0.642835:0.006397:0.004951:0.002717:0.007677:0.004793:0.001919:0.002234:0.002401:0.004955:0.002577
mildly :@0.286716:0.660628:0.311351:0.660628:0.311351:0.650990:0.286716:0.650990:0.007510:0.001762:0.001762:0.004951:0.001919:0.004154:0.002577
increased:@0.278724:0.668784:0.316960:0.668784:0.316960:0.659146:0.278724:0.659146:0.001762:0.004951:0.004321:0.002874:0.004951:0.004793:0.004478:0.004951:0.005155
 :@0.316769:0.668784:0.319346:0.668784:0.319346:0.659146:0.316769:0.659146:0.002577
Moderately :@0.346182:0.656732:0.392057:0.656732:0.392057:0.647095:0.346182:0.647095:0.007352:0.004951:0.004951:0.004951:0.002874:0.004793:0.002401:0.004793:0.002077:0.004154:0.002577
increased:@0.348899:0.665253:0.387135:0.665253:0.387135:0.655616:0.348899:0.655616:0.001762:0.004951:0.004321:0.002874:0.004951:0.004793:0.004478:0.004951:0.005155
 :@0.386944:0.665253:0.389521:0.665253:0.389521:0.655616:0.386944:0.655616:0.002577
Severely :@0.423710:0.656732:0.462419:0.656732:0.462419:0.647095:0.423710:0.647095:0.006230:0.005118:0.004636:0.005118:0.003199:0.005118:0.002234:0.004478:0.002577
increased:@0.421472:0.665253:0.461803:0.665253:0.461803:0.655616:0.421472:0.655616:0.002077:0.005118:0.004636:0.003041:0.005276:0.005118:0.004793:0.005118:0.005155
 :@0.461915:0.665253:0.464492:0.665253:0.464492:0.655616:0.461915:0.655616:0.002577
ACR* :@0.279044:0.685826:0.304959:0.685826:0.304959:0.676189:0.279044:0.676189:0.006230:0.006713:0.006713:0.003683:0.002577
   <30 :@0.267214:0.693981:0.293291:0.693981:0.293291:0.684344:0.267214:0.684344:0.002559:0.002559:0.002555:0.005433:0.005276:0.005118:0.002577
mg/g:@0.293270:0.693981:0.313937:0.693981:0.313937:0.684344:0.293270:0.684344:0.007834:0.005118:0.002559:0.005155
 :@0.314051:0.693981:0.316629:0.693981:0.316629:0.684344:0.314051:0.684344:0.002577
<3mg/mmol:@0.275527:0.702503:0.324434:0.702503:0.324434:0.692865:0.275527:0.692865:0.005433:0.005118:0.007834:0.005118:0.002559:0.007834:0.007834:0.005118:0.002058
 :@0.324442:0.702503:0.327019:0.702503:0.327019:0.692865:0.324442:0.692865:0.002577
ACR* :@0.353855:0.685826:0.379771:0.685826:0.379771:0.676189:0.353855:0.676189:0.006230:0.006713:0.006713:0.003683:0.002577
30–:@0.350658:0.693981:0.366043:0.693981:0.366043:0.684344:0.350658:0.684344:0.005118:0.005113:0.005155
300 mg/g:@0.366163:0.693981:0.405057:0.693981:0.405057:0.684344:0.366163:0.684344:0.005118:0.005276:0.005118:0.002559:0.007834:0.005118:0.002717:0.005155
 :@0.405167:0.693981:0.407745:0.693981:0.407745:0.684344:0.405167:0.684344:0.002577
3–:@0.343464:0.702503:0.353734:0.702503:0.353734:0.692865:0.343464:0.692865:0.005115:0.005155
30 mg/mmol:@0.353695:0.702503:0.405003:0.702503:0.405003:0.692865:0.353695:0.692865:0.005276:0.005118:0.002559:0.007834:0.005118:0.002559:0.007834:0.007834:0.005118:0.002058
 :@0.405167:0.702503:0.407745:0.702503:0.407745:0.692865:0.405167:0.692865:0.002577
ACR* :@0.427706:0.685826:0.453622:0.685826:0.453622:0.676189:0.427706:0.676189:0.006230:0.006713:0.006713:0.003683:0.002577
>300 mg/g:@0.423870:0.693981:0.468039:0.693981:0.468039:0.684344:0.423870:0.684344:0.005433:0.005118:0.005118:0.005276:0.002559:0.007834:0.005118:0.002559:0.005155
 :@0.468149:0.693981:0.470727:0.693981:0.470727:0.684344:0.468149:0.684344:0.002577
>30 mg/mmol:@0.416197:0.702503:0.472781:0.702503:0.472781:0.692865:0.416197:0.692865:0.005433:0.005118:0.005118:0.002559:0.007834:0.005118:0.002559:0.007834:0.007834:0.005118:0.002058
 :@0.472945:0.702503:0.475522:0.702503:0.475522:0.692865:0.472945:0.692865:0.002577
    eGFR categories (ml/min per :@0.088948:0.827902:0.088948:0.724539:0.075671:0.724539:0.075671:0.827902:0.000000:0.000000:0.000000:0.009724:0.005104:0.007017:0.005575:0.006537:-0.170375:0.000000:0.182968:0.003033:-0.186001:0.196513:0.005418:0.003504:0.002552:0.005104:-0.213090:0.000000:0.223445:0.008127:0.002395:0.002395:0.008284:0.002552:0.005418:-0.252615:0.260585:-0.260585:0.269205:0.002570
1.73m ) - description and range:@0.099978:0.820720:0.099978:0.718331:0.086701:0.718331:0.086701:0.820720:0.000000:0.007489:-0.142283:0.000000:0.000000:0.000000:0.000000:0.169066:0.002869:0.002550:0.005575:0.004937:0.005104:0.004937:0.003504:0.002552:-0.201095:0.209536:0.002552:-0.212088:0.223081:-0.223081:0.230580:0.005575:-0.236155:0.000000:0.247638:0.005104:-0.252741:0.263734:0.005141
2:@0.091422:0.801243:0.091422:0.798671:0.082724:0.798671:0.082724:0.801243:0.003368
 :@0.099505:0.718346:0.099505:0.716383:0.086849:0.716383:0.086849:0.718346:0.002570
G1:@0.122867:0.714797:0.135217:0.714797:0.135217:0.705160:0.122867:0.705160:0.007195:0.005155
 :@0.135336:0.714797:0.137913:0.714797:0.137913:0.705160:0.135336:0.705160:0.002577
Normal or high:@0.159953:0.714797:0.217520:0.714797:0.217520:0.705160:0.159953:0.705160:0.006397:0.004951:0.002717:0.007677:0.004793:0.001919:0.002234:0.004951:0.002874:0.002234:0.004951:0.001762:0.004951:0.005155
 :@0.217340:0.714797:0.219918:0.714797:0.219918:0.705160:0.217340:0.705160:0.002577
≥:@0.237801:0.714797:0.243675:0.714797:0.243675:0.705160:0.237801:0.705160:0.005873
90:@0.243876:0.714797:0.254149:0.714797:0.254149:0.705160:0.243876:0.705160:0.005118:0.005155
 :@0.254266:0.714797:0.256844:0.714797:0.256844:0.705160:0.254266:0.705160:0.002577
 :@0.301103:0.714797:0.303681:0.714797:0.303681:0.705160:0.301103:0.705160:0.002577
 :@0.371119:0.714797:0.373696:0.714797:0.373696:0.705160:0.371119:0.705160:0.002577
 :@0.444971:0.714797:0.447548:0.714797:0.447548:0.705160:0.444971:0.705160:0.002577
G2:@0.122867:0.730379:0.135217:0.730379:0.135217:0.720741:0.122867:0.720741:0.007195:0.005155
 :@0.135336:0.730379:0.137913:0.730379:0.137913:0.720741:0.135336:0.720741:0.002577
Mildly decreased:@0.155797:0.730379:0.221662:0.730379:0.221662:0.720741:0.155797:0.720741:0.007352:0.001919:0.001762:0.004951:0.001919:0.004154:0.002401:0.004951:0.004951:0.004311:0.002874:0.004951:0.004951:0.004311:0.004951:0.005155
 :@0.221496:0.730379:0.224074:0.730379:0.224074:0.720741:0.221496:0.720741:0.002577
60 –89:@0.236043:0.730379:0.263580:0.730379:0.263580:0.720741:0.236043:0.720741:0.005115:0.005155:0.001719:0.005275:0.005118:0.005155
 :@0.263698:0.730379:0.266275:0.730379:0.266275:0.720741:0.263698:0.720741:0.002577
 :@0.301103:0.730379:0.303681:0.730379:0.303681:0.720741:0.301103:0.720741:0.002577
 :@0.371119:0.730379:0.373696:0.730379:0.373696:0.720741:0.371119:0.720741:0.002577
 :@0.444971:0.730379:0.447548:0.730379:0.447548:0.720741:0.444971:0.720741:0.002577
G3a:@0.120310:0.746934:0.137777:0.746934:0.137777:0.737296:0.120310:0.737296:0.007195:0.005118:0.005155
 :@0.137894:0.746934:0.140471:0.746934:0.140471:0.737296:0.137894:0.737296:0.002577
Mildly to moderately  45–59:@0.150042:0.746934:0.261822:0.746934:0.261822:0.737296:0.150042:0.737296:0.007352:0.001919:0.001762:0.004951:0.001919:0.004154:0.002401:0.002401:0.004793:0.002234:0.007677:0.004951:0.004951:0.004951:0.002717:0.004951:0.002401:0.004793:0.001919:0.004154:0.002577:0.006071:0.005118:0.005113:0.005275:0.005118:0.005155
decreased:@0.168106:0.755089:0.209373:0.755089:0.209373:0.745452:0.168106:0.745452:0.004951:0.004793:0.004478:0.002874:0.004793:0.004951:0.004478:0.004793:0.005155
 :@0.209188:0.755089:0.211765:0.755089:0.211765:0.745452:0.209188:0.745452:0.002577
 :@0.261939:0.746934:0.264517:0.746934:0.264517:0.737296:0.261939:0.737296:0.002577
 :@0.301103:0.746934:0.303681:0.746934:0.303681:0.737296:0.301103:0.737296:0.002577
 :@0.371119:0.746934:0.373696:0.746934:0.373696:0.737296:0.371119:0.737296:0.002577
Refer :@0.433461:0.746934:0.458898:0.746934:0.458898:0.737296:0.433461:0.737296:0.006713:0.005118:0.002559:0.005276:0.003194:0.002577
G3b:@0.120310:0.768723:0.137777:0.768723:0.137777:0.759086:0.120310:0.759086:0.007195:0.005118:0.005155
 :@0.137894:0.768723:0.140471:0.768723:0.140471:0.759086:0.137894:0.759086:0.002577
Moderately  to :@0.159314:0.768723:0.217177:0.768723:0.217177:0.759086:0.159314:0.759086:0.007352:0.004951:0.004951:0.004951:0.002874:0.004793:0.002401:0.004793:0.002077:0.004154:0.002401:0.002401:0.002234:0.004951:0.002577
severely :@0.170823:0.776879:0.205832:0.776879:0.205832:0.767242:0.170823:0.767242:0.004311:0.004951:0.004478:0.004793:0.002874:0.004793:0.002077:0.004154:0.002577
decreased:@0.166507:0.785035:0.207775:0.785035:0.207775:0.775398:0.166507:0.775398:0.004951:0.004793:0.004478:0.002874:0.004793:0.004951:0.004478:0.004793:0.005155
 :@0.207589:0.785035:0.210167:0.785035:0.210167:0.775398:0.207589:0.775398:0.002577
30–44:@0.236043:0.768723:0.261822:0.768723:0.261822:0.759086:0.236043:0.759086:0.005118:0.005113:0.005275:0.005118:0.005155
 :@0.261939:0.768723:0.264517:0.768723:0.264517:0.759086:0.261939:0.759086:0.002577
 :@0.301103:0.768723:0.303681:0.768723:0.303681:0.759086:0.301103:0.759086:0.002577
Refer :@0.359769:0.768723:0.385206:0.768723:0.385206:0.759086:0.359769:0.759086:0.006713:0.005118:0.002559:0.005276:0.003194:0.002577
Refer :@0.433461:0.768723:0.458898:0.768723:0.458898:0.759086:0.433461:0.759086:0.006713:0.005118:0.002559:0.005276:0.003194:0.002577
G4:@0.122867:0.798060:0.135217:0.798060:0.135217:0.788422:0.122867:0.788422:0.007195:0.005155
 :@0.135336:0.798060:0.137913:0.798060:0.137913:0.788422:0.135336:0.788422:0.002577
Severely :@0.175139:0.798060:0.211743:0.798060:0.211743:0.788422:0.175139:0.788422:0.005915:0.004951:0.004311:0.004951:0.002874:0.004793:0.002077:0.004154:0.002577
decreased:@0.171622:0.806216:0.212890:0.806216:0.212890:0.796578:0.171622:0.796578:0.004951:0.004793:0.004478:0.002874:0.004793:0.004951:0.004478:0.004793:0.005155
 :@0.212705:0.806216:0.215282:0.806216:0.215282:0.796578:0.212705:0.796578:0.002577
15–29:@0.235883:0.798060:0.261662:0.798060:0.261662:0.788422:0.235883:0.788422:0.005118:0.005113:0.005275:0.005118:0.005155
 :@0.261779:0.798060:0.264357:0.798060:0.264357:0.788422:0.261779:0.788422:0.002577
Refer :@0.289594:0.798060:0.315030:0.798060:0.315030:0.788422:0.289594:0.788422:0.006713:0.005118:0.002559:0.005276:0.003194:0.002577
Refer :@0.359769:0.798060:0.385206:0.798060:0.385206:0.788422:0.359769:0.788422:0.006713:0.005118:0.002559:0.005276:0.003194:0.002577
Refer :@0.433461:0.798060:0.458898:0.798060:0.458898:0.788422:0.433461:0.788422:0.006713:0.005118:0.002559:0.005276:0.003194:0.002577
G5:@0.122867:0.819362:0.135217:0.819362:0.135217:0.809725:0.122867:0.809725:0.007195:0.005155
 :@0.135336:0.819362:0.137913:0.819362:0.137913:0.809725:0.135336:0.809725:0.002577
Kidney failure:@0.165868:0.819362:0.218808:0.819362:0.218808:0.809725:0.165868:0.809725:0.005915:0.001762:0.004951:0.004951:0.004951:0.004154:0.002401:0.002401:0.004951:0.001762:0.001919:0.004793:0.002874:0.005155
 :@0.218619:0.819362:0.221197:0.819362:0.221197:0.809725:0.218619:0.809725:0.002577
<15:@0.243556:0.819362:0.259262:0.819362:0.259262:0.809725:0.243556:0.809725:0.005433:0.005118:0.005155
 :@0.259382:0.819362:0.261959:0.819362:0.261959:0.809725:0.259382:0.809725:0.002577
Refer :@0.289594:0.819362:0.315030:0.819362:0.315030:0.809725:0.289594:0.809725:0.006713:0.005118:0.002559:0.005276:0.003194:0.002577
Refer :@0.359769:0.819362:0.385206:0.819362:0.385206:0.809725:0.359769:0.809725:0.006713:0.005118:0.002559:0.005276:0.003194:0.002577
Refer :@0.433461:0.819362:0.458898:0.819362:0.458898:0.809725:0.433461:0.809725:0.006713:0.005118:0.002559:0.005276:0.003194:0.002577
 :@0.076190:0.845355:0.079523:0.845355:0.079523:0.832893:0.076190:0.832893:0.003333
figure 1. Assessing risk and referral in relation to ACr :@0.076190:0.931567:0.464145:0.931567:0.464145:0.915069:0.076190:0.915069:0.007257:0.003629:0.009979:0.009071:0.004838:0.009676:0.004233:0.008467:0.004233:0.004233:0.011188:0.006652:0.006652:0.009676:0.006652:0.006652:0.003629:0.009071:0.009979:0.004233:0.004838:0.003629:0.006652:0.008769:0.004233:0.009979:0.009071:0.009979:0.004233:0.004838:0.009676:0.004233:0.009676:0.004838:0.004838:0.009979:0.003629:0.004233:0.003629:0.009071:0.004233:0.004838:0.009676:0.003629:0.009979:0.004536:0.003629:0.009676:0.009071:0.004233:0.004536:0.009676:0.004233:0.011188:0.011793:0.008769:0.004233
and eGfr:@0.076190:0.945676:0.147855:0.945676:0.147855:0.929177:0.076190:0.929177:0.009979:0.009071:0.009979:0.004233:0.009676:0.012700:0.007257:0.008769
Green – low risk (if no other markers of kidney disease, no CKD); yellow – :@0.076190:0.849001:0.484213:0.849001:0.484213:0.836725:0.076190:0.836725:0.010254:0.003540:0.007644:0.007644:0.007173:0.003010:0.005880:0.003022:0.002352:0.007702:0.009772:0.003022:0.003540:0.002352:0.004563:0.005903:0.003022:0.004339:0.002352:0.003692:0.003022:0.007173:0.007702:0.003010:0.007702:0.003986:0.007173:0.007644:0.003540:0.003010:0.011030:0.008032:0.003540:0.005903:0.007644:0.003540:0.004563:0.003010:0.007702:0.003692:0.003010:0.005903:0.002352:0.008055:0.007173:0.007644:0.006303:0.003022:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003022:0.007173:0.007702:0.003010:0.009560:0.006950:0.008749:0.004339:0.003257:0.003010:0.006303:0.007644:0.002352:0.002352:0.007702:0.009772:0.003022:0.005880:0.003257
moderately increased risk; orange – high risk; red – very high risk; A1, A2, :@0.076190:0.859902:0.484248:0.859902:0.484248:0.847627:0.076190:0.847627:0.011030:0.007702:0.008055:0.007644:0.003540:0.008032:0.003986:0.007644:0.002352:0.006303:0.003069:0.002352:0.007173:0.007608:0.003540:0.007644:0.008032:0.004563:0.007644:0.008055:0.003069:0.003540:0.002352:0.004563:0.005903:0.003257:0.003069:0.007702:0.003540:0.008032:0.007173:0.007914:0.007644:0.003057:0.005880:0.003069:0.007173:0.002352:0.007914:0.007173:0.003069:0.003540:0.002352:0.004563:0.005903:0.003257:0.003069:0.003540:0.007644:0.008055:0.003069:0.005880:0.003069:0.006515:0.007644:0.003540:0.006303:0.003069:0.007173:0.002352:0.007914:0.007173:0.003069:0.003540:0.002352:0.004563:0.005903:0.003257:0.003069:0.008702:0.006515:0.003257:0.003069:0.008702:0.006515:0.003257:0.003257
A3 – categories of albuminuria; G1, G2, G3a, G3b, G4, G5 – categories :@0.076190:0.870804:0.484213:0.870804:0.484213:0.858528:0.076190:0.858528:0.008702:0.006515:0.003422:0.005880:0.003422:0.007608:0.008032:0.003986:0.007644:0.007914:0.007702:0.003540:0.002352:0.007644:0.004563:0.003410:0.007702:0.003692:0.003410:0.008032:0.002352:0.008020:0.007150:0.011030:0.002352:0.007173:0.007150:0.003540:0.002352:0.008032:0.003257:0.003422:0.010254:0.006515:0.003257:0.003422:0.010254:0.006515:0.003257:0.003422:0.010254:0.006515:0.008032:0.003257:0.003422:0.010254:0.006515:0.008020:0.003257:0.003422:0.010254:0.006515:0.003257:0.003422:0.010254:0.006515:0.003422:0.005880:0.003422:0.007608:0.008032:0.003986:0.007644:0.007914:0.007702:0.003540:0.002352:0.007644:0.004563:0.003257
of eGFR.:@0.076190:0.881705:0.124838:0.881705:0.124838:0.869430:0.076190:0.869430:0.007702:0.003692:0.003257:0.007644:0.010254:0.005703:0.007138:0.003257
Adapted from Levin A, stevens pE. summary of KDIGO 2012 CKD Guide-:@0.076190:0.892607:0.480932:0.892607:0.480932:0.880331:0.076190:0.880331:0.008702:0.008055:0.008032:0.008020:0.003986:0.007644:0.008055:0.002857:0.003692:0.003540:0.007702:0.011030:0.002857:0.005433:0.007644:0.006515:0.002352:0.007173:0.002857:0.008702:0.003257:0.002869:0.005856:0.003986:0.007644:0.006515:0.007644:0.007173:0.004563:0.002857:0.006961:0.006303:0.003257:0.002857:0.005856:0.007150:0.011030:0.011030:0.008032:0.003540:0.006303:0.002857:0.007702:0.003692:0.002857:0.006950:0.008749:0.002658:0.010254:0.010219:0.002869:0.006515:0.006515:0.006515:0.006515:0.002869:0.009560:0.006950:0.008749:0.002857:0.010254:0.007150:0.002352:0.008055:0.007644:0.003904
line: Behind the scenes, need for guidance, and a framework for mov-:@0.076179:0.903508:0.480956:0.903508:0.480956:0.891233:0.076179:0.891233:0.002352:0.002352:0.007173:0.007644:0.003257:0.003704:0.006750:0.007644:0.007173:0.002352:0.007173:0.008055:0.003704:0.003986:0.007173:0.007644:0.003704:0.004563:0.007608:0.007644:0.007173:0.007644:0.004563:0.003257:0.003704:0.007173:0.007644:0.007644:0.008055:0.003704:0.003692:0.007702:0.003540:0.003704:0.007914:0.007150:0.002352:0.008055:0.008032:0.007173:0.007608:0.007644:0.003257:0.003704:0.008032:0.007173:0.008055:0.003704:0.008032:0.003704:0.003692:0.003540:0.008032:0.011030:0.007644:0.009772:0.007702:0.003540:0.005903:0.003692:0.003692:0.007702:0.003540:0.003704:0.011030:0.007702:0.006515:0.003904
ing forward. :@0.076179:0.914410:0.147722:0.914410:0.147722:0.902134:0.076179:0.902134:0.002352:0.007173:0.007914:0.003257:0.003692:0.007702:0.003540:0.009772:0.008032:0.003540:0.008055:0.003257:0.003257
Kidney Int.:@0.147710:0.914410:0.206518:0.914410:0.206518:0.902134:0.147710:0.902134:0.006950:0.002352:0.008055:0.007173:0.007644:0.006303:0.003257:0.002658:0.007173:0.003986:0.003257
 2014 Jan;85(1):49-61.:@0.206506:0.914410:0.327909:0.914410:0.327909:0.902134:0.206506:0.902134:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.005668:0.008032:0.007173:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
2:@0.092943:0.806524:0.092943:0.804369:0.085741:0.804369:0.085741:0.806524:0.002822